BCAL Diagnostics Limited (AU:BDX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BCAL Diagnostics Limited is set to hold its Annual General Meeting on November 22, 2024, where shareholders will review financial reports and vote on key resolutions, including the re-election of director Ronald Phillips. Investors have the opportunity to engage and vote, either in person or by proxy, on various resolutions that will shape the company’s future. This meeting is a pivotal event for stakeholders to assess BCAL’s strategic direction and governance.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.